(Q46632076)

23 December 2017

title

Capecitabine as third line therapy in patients with advanced colorectal cancer (English)

1 reference

23 December 2017

0 references

0 references

1 reference

Michael Gubanski

1

1 reference

23 December 2017

Gisela Naucler

2

1 reference

23 December 2017

Agneta Almerud

3

1 reference

23 December 2017

Anders Lideståhl

4

1 reference

23 December 2017

Pehr A R M Lind

5

1 reference

23 December 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

23 December 2017

published in

Acta Oncologica

1 reference

23 December 2017

volume

44

1 reference

23 December 2017

issue

3

1 reference

23 December 2017

page(s)

236-239

1 reference

23 December 2017

Metastatic colorectal cancer

cites work

1 reference

https://api.crossref.org/works/10.1080%2F02841860510029662

Tumor selective delivery of 5-fluorouracil by capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510029662

Capecitabine: preclinical pharmacology studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510029662

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510029662

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510029662

Phase II study of capecitabine in patients with fluorouracil-resistant metastatic colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510029662

10.1080/02841860510029662

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017